Ming Luo

机构：Hubei University of Medicine, Tianjin Medical University Cancer Institute and Hospital, Taihe Hospital, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0003-2577-1904

发表论文 85 篇 · 总被引 2294 次 · h-index 19

代表论文

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis (2023 · World Journal of Gastroenterology · 被引 46)
Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin‐like effect and increased haemorrhagic risk (2024 · British Journal of Haematology · 被引 20)
Fecal microbiota transplantation alleviates cirrhotic portal hypertension in rats via butyrate-mediated HDAC3 inhibition and PI3K/Akt/eNOS signaling regulation (2025 · European Journal of Pharmacology · 被引 13)
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis (2022 · Expert Review of Gastroenterology & Hepatology · 被引 10)
EncephalApp stroop test versus electronic number connection test-A for screening minimal hepatic encephalopathy in patients with liver cirrhosis: a comparative study (2022 · Scandinavian Journal of Gastroenterology · 被引 8)
Novel computerized psychometric tests as primary screening tools for the diagnosis of minimal hepatic encephalopathy (2020 · World Journal of Clinical Cases · 被引 6)